Standout Papers

JAK inhibitors and the risk of malignancy: a meta-analysis across disease indications 2023 2026 202468
  1. JAK inhibitors and the risk of malignancy: a meta-analysis across disease indications (2023)
    Mark Russell, Edward Alveyn et al. Annals of the Rheumatic Diseases

Immediate Impact

39 standout
Sub-graph 1 of 14

Citing Papers

U-Net-Based Models for Precise Brain Stroke Segmentation
2025 Standout
Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer
2025 Standout
2 intermediate papers

Works of Edward Alveyn being referenced

Deep learning for detecting tumour-infiltrating lymphocytes in testicular germ cell tumours
2018

Author Peers

Author Last Decade Papers Cites
Edward Alveyn 55 36 9 30 22 156
Matheus Vieira 58 31 99 21 17 227
Jakob Hjorth von Stemann 11 74 19 15 19 183
E HENDERSON 28 20 4 34 16 160
Adrian Levitsky 105 31 2 16 20 158
Marco Giunti 50 20 9 11 21 157
Jorge Pinheiro 19 15 13 43 31 206
Shachar Sade 17 31 85 21 203
Bal M. Dhungel 16 27 11 96 19 195
Ashira Blazer 135 106 40 28 21 246
Andrea Aroldi 19 34 7 50 20 152

All Works

Loading papers...

Rankless by CCL
2026